GCM Grosvenor
GCMG
13.20
+0.23
+1.77%
GCM Grosvenor
US · GCMG
#3427 by market cap
Listed 2020
13.20
+0.23
+1.77%
Live - 5344 symbols - heartbeat 150s ago
· 2026-10-09 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 8.6 percentage points.
Institutional ownership
- Held by institutions
- 93.96% -8.57pp
- Institutions
- 181 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund78.40%
Hedge Fund7.44%
Public Company6.99%
Individual/Insider2.82%
Private Company0.38%
Sovereign Wealth Fund0.32%
Government Pension Fund0.22%
Insurance Company0.17%
Other3.23%
Top holders as of 2026-07-16
Cantor Fitzgerald Asset Management
9.64% · 5.89M sh
Columbia Management Investment Advisers, LLC
8.83% · 5.40M sh
BlackRock
7.79% · 4.76M sh
Ariel Investments, LLC
7.22% · 4.42M sh
Sumitomo Mitsui Trust Asset Management
6.14% · 3.75M sh
Vanguard Capital Management, LLC
4.93% · 3.01M sh
Vanguard Portfolio Management, LLC
4.32% · 2.64M sh
Mizuho Financial Group, Inc.
3.98% · 2.43M sh
Baron Capital Group, Inc.
3.61% · 2.20M sh
Royce & Associates, LP
2.92% · 1.78M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 22 sells
| Name | Role | Stake |
|---|---|---|
| Frederick Pollock | MD, Chief Investment Officer & Head of Strategic Investment Group | 1.33% |
| Jonathan Levin | President, MD & Director | 1.13% |
| Francesca Cornelli | Independent Director | 0.09% |
| Sandra Hurse | MD & Chief Human Resources Officer | 0.08% |
| Angela Blanton | Independent Director | 0.07% |
| Kathleen Sullivan | Head of Accounting & Financial Reporting and MD of Finance in Chicago | 0.07% |
| Pamela Bentley | MD & CFO | 0.02% |
| Samuel Scott | Lead Independent Director | 0.02% |
| David Helfand | Independent Director | -- |
| Howard Lutnick | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | David Helfand | Independent Director | Other Derivative Acquisition | +6,886 | -- |
| 2026-09-29 | Samuel Scott | Lead Independent Director | Other Derivative Acquisition | +5,722 | -- |
| 2026-09-29 | Francesca Cornelli | Independent Director | Other Acquisition | +5,722 | $12.89 |
| 2026-09-29 | Stephen Malkin | Non-Independent Director | Other Derivative Acquisition | +4,849 | -- |
| 2026-09-15 | Pamela Bentley | MD & CFO | Automatic Disposition | -50,000 | $12.56–12.68 |
| 2026-09-15 | Pamela Bentley | MD & CFO | Intent to Sell (Form 144) | -10,000 | $12.76 |
| 2026-09-14 | Pamela Bentley | MD & CFO | Intent to Sell (Form 144) | -40,000 | $12.64 |
| 2026-09-02 | Kathleen Sullivan | Head of Accounting & Financial Reporting and MD of Finance in Chicago | Open Market Disposition | -40,000 | $13.15–13.16 |
| 2026-08-14 | Jonathan Levin | President, MD & Director | Derivative Exercise and Sale | -42,813 | $13.86 |
| 2026-08-14 | Jonathan Levin | President, MD & Director | Derivative Exercise and Retained | +48,492 | -- |
| 2026-08-14 | Frederick Pollock | MD, Chief Investment Officer & Head of Strategic Investment Group | Derivative Exercise and Sale | -23,953 | $13.86 |
| 2026-08-14 | Frederick Pollock | MD, Chief Investment Officer & Head of Strategic Investment Group | Derivative Exercise and Retained | +36,917 | -- |
| 2026-07-15 | Cantor Fitzgerald Asset Management | -- | Open Market Disposition | -553,106 | $13.57–13.83 |
| 2026-07-14 | Cantor Fitzgerald Asset Management | -- | Private Disposition | -4,000 | $14.24 |
| 2026-06-29 | David Helfand | Independent Director | Other Derivative Acquisition | +7,216 | -- |
| 2026-06-29 | Samuel Scott | Lead Independent Director | Other Derivative Acquisition | +5,996 | -- |
| 2026-06-29 | Francesca Cornelli | Independent Director | Other Acquisition | +5,996 | $12.30 |
| 2026-06-29 | Stephen Malkin | Non-Independent Director | Other Derivative Acquisition | +5,082 | -- |
| 2026-05-30 | Jonathan Levin | President, MD & Director | Derivative Exercise and Sale | -45,085 | $10.63 |
| 2026-05-30 | Jonathan Levin | President, MD & Director | Derivative Exercise and Retained | +54,157 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
GCM Grosvenor discussion 0 comments